Hammilton
Bluelighter
- Joined
- Sep 2, 2008
- Messages
- 3,435
How would you classify modafinil?
It binds to DAT, increases MA levels, has odd H3 effects.
hypocretin? Never even heard of it until now. Oh, it's orexin.
from wiki:
It seems to not be recreational, but all of mechanisms seem to scream recreational. So why not?
I've taken it two days now (at 175, tommorow I'll go to 200 where I was supposed to start, but better safe than sorry- I was up until 3am last night), and I don't know that I could distinguish it from a low dose of amphetamine. Definitely not like a DARI, which even at low doses I experienced euphoria, but with amphetamine I never did. I don't have any euphoria, but it is still useful.
It's probably the most mentally boosting drug I've ever used.
Also, I've seen some 'modafinil analogues' of phenyltropanes made that were insanely potent; have similar things been tried for regular PEAs or is the ethylamine to short to stick the sulfur into?
It binds to DAT, increases MA levels, has odd H3 effects.
There have been some preclinical studies of potential wakefulness-inducing treatments that work biochemically by inhibiting the histamine H3 receptor in the brain. However, modafinil has behavioral effects even in mice whose H3 receptor is genetically knocked out (6). It is possible that modafinil is working on the hypocretin system (7), a unique peptide neurotransmitter system that is abnormal in narcolepsy but is unlikely to be a key player in the biochemical mechanism of bipolar depression. Therefore, one could think of modafinil as a nonspecific or symptomatic treatment of bipolar depression.
hypocretin? Never even heard of it until now. Oh, it's orexin.
from wiki:
Pharmacology
The exact mechanism of action of Modafinil is unclear, although numerous in vitro studies have shown it to increase the levels of various monoamines, namely; dopamine in the striatum and nucleus accumbens,[54][55] noradrenalin in the hypothalamus and ventrolateral preoptic nucleus,[56][57] and serotonin in the amygdala and frontal cortex.[58] While the co-administration of a dopamine antagonist is known to decrease the stimulant effect of amphetamine, it does not negate the wakefulness-promoting actions of modafinil. Modafinil activates glutamatergic circuits while inhibiting GABAergic neurotransmission. Modafinil is thought to have less potential for abuse than other stimulants due to the absence of any significant euphoric or pleasurable effects.
The central stimulating effect of modafinil shows dose and time-related features. The effect tends to be enhanced by chlorination but reduced by methylation. Modafinil blocks the reuptake of norepinephrine by the noradrenergic terminals on sleep-promoting neurons from the ventrolateral preoptic nucleus (VLPO). Such a mechanism could be at least partially responsible for the wake-promoting effect of modafinil.
Modafinil has a binding coefficient (Ki) of about 4,000 nmol/L for the dopamine reuptake transporter, and in excess of 10,000 nmol/L for the norepinephrine reuptake transporter.
A newly proposed mechanism of action involves brain peptides called orexins, also known as hypocretins. Orexin neurons are found in the hypothalamus but project to many different parts of the brain, including several areas that regulate wakefulness. Activation of these neurons increases dopamine and norepinephrine in these areas, and excite histaminergic tuberomammillary neurons increasing histamine levels there. There are two receptors for hypocretins, namely hcrt1 and hcrt2. Animal studies have shown that animals with defective orexin systems show signs and symptoms similar to narcolepsy. Modafinil seems to activate these orexin neurons thus promoting wakefulness. However, a study of genetically modified dogs lacking orexin receptors showed that modafinil still promoted wakefulness in these animals, suggesting that orexin activation is not required for the effects of modafinil.
It is possible that modafinil acts by a synergistic combination of mechanisms including direct inhibition of dopamine and norepinephrine reuptake, as well as orexin activation.
It has been shown in rats that modafinil increases histamine release in the brain, and this may be a possible mechanism of action in humans.[59]
Armodafinil a single R-enantiomer of modafinil was approved by the FDA for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome and shift work sleep disorder.
It seems to not be recreational, but all of mechanisms seem to scream recreational. So why not?
I've taken it two days now (at 175, tommorow I'll go to 200 where I was supposed to start, but better safe than sorry- I was up until 3am last night), and I don't know that I could distinguish it from a low dose of amphetamine. Definitely not like a DARI, which even at low doses I experienced euphoria, but with amphetamine I never did. I don't have any euphoria, but it is still useful.
It's probably the most mentally boosting drug I've ever used.
Also, I've seen some 'modafinil analogues' of phenyltropanes made that were insanely potent; have similar things been tried for regular PEAs or is the ethylamine to short to stick the sulfur into?